These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 26074073

  • 1. A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.
    Mao DD, Gujar AD, Mahlokozera T, Chen I, Pan Y, Luo J, Brost T, Thompson EA, Turski A, Leuthardt EC, Dunn GP, Chicoine MR, Rich KM, Dowling JL, Zipfel GJ, Dacey RG, Achilefu S, Tran DD, Yano H, Kim AH.
    Cell Rep; 2015 Jun 23; 11(11):1809-21. PubMed ID: 26074073
    [Abstract] [Full Text] [Related]

  • 2. CDC20 maintains tumor initiating cells.
    Xie Q, Wu Q, Mack SC, Yang K, Kim L, Hubert CG, Flavahan WA, Chu C, Bao S, Rich JN.
    Oncotarget; 2015 May 30; 6(15):13241-54. PubMed ID: 25938542
    [Abstract] [Full Text] [Related]

  • 3. The CDC20-APC/SOX2 signaling axis: An achilles' heel for glioblastoma.
    Gujar AD, Yano H, Kim AH.
    Mol Cell Oncol; 2016 May 30; 3(3):e1075644. PubMed ID: 27314081
    [Abstract] [Full Text] [Related]

  • 4. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca2+ /calmodulin-dependent protein kinase II.
    Shin HJ, Lee S, Jung HJ.
    J Cell Biochem; 2019 Apr 30; 120(4):6741-6752. PubMed ID: 30390339
    [Abstract] [Full Text] [Related]

  • 5. CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells.
    Mao DD, Cleary RT, Gujar A, Mahlokozera T, Kim AH.
    PLoS One; 2022 Apr 30; 17(6):e0270251. PubMed ID: 35737702
    [Abstract] [Full Text] [Related]

  • 6. Role of ubiquitylation of components of mitotic checkpoint complex in their dissociation from anaphase-promoting complex/cyclosome.
    Sitry-Shevah D, Kaisari S, Teichner A, Miniowitz-Shemtov S, Hershko A.
    Proc Natl Acad Sci U S A; 2018 Feb 20; 115(8):1777-1782. PubMed ID: 29432156
    [Abstract] [Full Text] [Related]

  • 7. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP, Prado MB, Cruz L, Martins VR, Santos TG, Lopes MH.
    Stem Cell Res Ther; 2017 Apr 17; 8(1):76. PubMed ID: 28412969
    [Abstract] [Full Text] [Related]

  • 8. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
    Koyama-Nasu R, Haruta R, Nasu-Nishimura Y, Taniue K, Katou Y, Shirahige K, Todo T, Ino Y, Mukasa A, Saito N, Matsui M, Takahashi R, Hoshino-Okubo A, Sugano H, Manabe E, Funato K, Akiyama T.
    Oncogene; 2014 Apr 24; 33(17):2236-44. PubMed ID: 23686309
    [Abstract] [Full Text] [Related]

  • 9. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
    Soroceanu L, Matlaf L, Khan S, Akhavan A, Singer E, Bezrookove V, Decker S, Ghanny S, Hadaczek P, Bengtsson H, Ohlfest J, Luciani-Torres MG, Harkins L, Perry A, Guo H, Soteropoulos P, Cobbs CS.
    Cancer Res; 2015 Aug 01; 75(15):3065-76. PubMed ID: 26239477
    [Abstract] [Full Text] [Related]

  • 10. Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/CCDH1 Activity and Pharmacologic Inhibition of APC/CCDH1/CDC20 Compromises Viability.
    De K, Grubb TM, Zalenski AA, Pfaff KE, Pal D, Majumder S, Summers MK, Venere M.
    Mol Cancer Res; 2019 Jul 01; 17(7):1519-1530. PubMed ID: 31036696
    [Abstract] [Full Text] [Related]

  • 11. CDC20 promotes bone formation via APC/C dependent ubiquitination and degradation of p65.
    Du Y, Zhang M, Liu X, Li Z, Hu M, Tian Y, Lv L, Zhang X, Liu Y, Zhang P, Zhou Y.
    EMBO Rep; 2021 Sep 06; 22(9):e52576. PubMed ID: 34382737
    [Abstract] [Full Text] [Related]

  • 12. Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.
    Guerrero PA, Tchaicha JH, Chen Z, Morales JE, McCarty N, Wang Q, Sulman EP, Fuller G, Lang FF, Rao G, McCarty JH.
    Oncogene; 2017 Nov 23; 36(47):6568-6580. PubMed ID: 28783169
    [Abstract] [Full Text] [Related]

  • 13. Deregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of Cdc20-anaphase-promoting complex/cyclosome.
    Nath S, Chowdhury A, Dey S, Roychoudhury A, Ganguly A, Bhattacharyya D, Roychoudhury S.
    Mol Cell Biol; 2015 Jan 23; 35(2):356-69. PubMed ID: 25368385
    [Abstract] [Full Text] [Related]

  • 14. APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.
    Schrock MS, Stromberg BR, Scarberry L, Summers MK.
    Semin Cancer Biol; 2020 Dec 23; 67(Pt 2):80-91. PubMed ID: 32165320
    [Abstract] [Full Text] [Related]

  • 15. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
    Peñaranda-Fajardo NM, Meijer C, Liang Y, Dijkstra BM, Aguirre-Gamboa R, den Dunnen WFA, Kruyt FAE.
    Cell Death Dis; 2019 Sep 18; 10(10):690. PubMed ID: 31534165
    [Abstract] [Full Text] [Related]

  • 16. Interphase APC/C-Cdc20 inhibition by cyclin A2-Cdk2 ensures efficient mitotic entry.
    Hein JB, Nilsson J.
    Nat Commun; 2016 Mar 10; 7():10975. PubMed ID: 26960431
    [Abstract] [Full Text] [Related]

  • 17. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
    Berezovsky AD, Poisson LM, Cherba D, Webb CP, Transou AD, Lemke NW, Hong X, Hasselbach LA, Irtenkauf SM, Mikkelsen T, deCarvalho AC.
    Neoplasia; 2014 Mar 10; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
    [Abstract] [Full Text] [Related]

  • 18. APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase.
    Amador V, Ge S, Santamaría PG, Guardavaccaro D, Pagano M.
    Mol Cell; 2007 Aug 03; 27(3):462-73. PubMed ID: 17679094
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B, Mughal AA, Grieg Z, Sandberg CJ, Joel M, Nygård S, Meling T, Murrell W, Vik Mo EO, Langmoen IA.
    Oncotarget; 2015 Sep 22; 6(28):26192-215. PubMed ID: 26295306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.